AVAI BIO, INC. Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)
AVAI BIO, INC. (AVAI) reported Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) of -$9.19 thousand for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Income Statement › Other Income
us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss · last filed 2023-02-14
- AVAI BIO, INC. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2022-12-31 was -$9.19K.
- AVAI BIO, INC. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2022-03-31 was $18.58K.
- AVAI BIO, INC. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2021-12-31 was -$1.58K.
- AVAI BIO, INC. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2021-09-30 was -$26.97K.
- AVAI BIO, INC. finite lived intangible assets, foreign currency translation gain (loss) for fiscal 2022 was -$11.63K, a 202.06% decline from fiscal 2021.
- AVAI BIO, INC. finite lived intangible assets, foreign currency translation gain (loss) for fiscal 2021 was $11.39K.
| Period end | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 3 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 6 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 9 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 12 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -$9.19K 10-Q · filed 2023-02-14 | ||||
| 2022-03-31 | $18.58K derived: 10-K 12 month − 3 quarters · filed 2022-06-29 | $16.99K derived: sum of 2 quarters · filed 2022-06-29 | -$9.97K derived: sum of 3 quarters · filed 2022-06-29 | -$11.63K 10-K · filed 2022-06-29 | |
| 2021-12-31 | -$1.58K 10-Q · filed 2022-02-14 | -$28.55K derived: sum of 2 quarters · filed 2022-02-14 | -$30.20K derived: sum of 3 quarters · filed 2022-02-14 | ||
| 2021-09-30 | -$26.97K 10-Q · filed 2022-02-14 | -$28.62K derived: sum of 2 quarters · filed 2022-02-14 | |||
| 2021-06-30 | -$1.65K 10-Q · filed 2021-08-23 | ||||
| 2021-03-31 | $11.39K 10-K/A · filed 2021-08-18 | $9.53K 10-K · filed 2021-07-13 |